D. Harvey

发表

Effect of CYP 3 A inhibitors on the pharmacokinetics of pevonedistat in patients with advanced solid tumours

J. Nemunaitis, D. Faller, Craig A. Lockhart, 2022 .

Randomized double-blind study of the Reliefband as an adjunct to standard antiemetics in patients receiving moderately-high to highly emetogenic chemotherapy

C. Lindley, S. Shord, I. Treish, 2003, Supportive Care in Cancer.

Off-label use of recombinant factor VIIa in patients following bone marrow transplantation

P. Monahan, J. Blatt, H. Cooper, 2001, Bone Marrow Transplantation.

FLAG is a useful regimen for poor prognosis adult myeloid leukaemias and myelodysplastic syndromes.

T. Nokes, A. Goldstone, A. Goldstone, 1997, Leukemia & lymphoma.

Cytoprotection by amifostine during autologous stem cell transplantation for advanced refractory hematologic malignancies.

J. Serody, T. Shea, S. Kirby, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Decrease in CD4 lymphocyte counts with rest; implications for the monitoring of HIV infection

P. Campbell, D. Harvey, S. Aurelius, 1997, International journal of STD & AIDS.

Pharmacokinetics of cytosine arabinoside in patients with acute myeloid leukaemia.

A. Harris, D. Grahame-Smith, J. Boutagy, 1979, British journal of clinical pharmacology.

Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck

F. Khuri, D. Shin, T. Owonikoko, 2014, Cancer.

Intraindividual variability in busulfan pharmacokinetics in patients undergoing a bone marrow transplant: assessment of a test dose and first dose strategy.

J. Serody, T. Shea, W. Petros, 2004, Anti-cancer drugs.

Assessing experimental visceral pain in dairy cattle: A pilot, prospective, blinded, randomized, and controlled study focusing on spinal pain proteomics.

E. Troncy, J. D. Del Castillo, F. Beaudry, 2014, Journal of dairy science.

A phase I MMRC clinical trial testing the combination of bortezomib and tipifarnib in relapsed/refractory multiple myeloma.

S. Lonial, S. Trudel, J. Kaufman, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I Study of the Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients with Advanced Solid Tumors

Jeffrey W. Clark, G. Mulligan, G. Shapiro, 2015, Clinical Cancer Research.

Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee.

M. I. Saunders, M. Parmar, A. Barrett, 1996, British Journal of Cancer.

Small molecule inhibition of the CHFR-PARP1 interaction as novel approach to overcome intrinsic taxane resistance in cancer

F. Khuri, Ge Li, P. Vertino, 2015, Oncotarget.

Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma

G. Mulligan, S. Tirrell, A. Jakubowiak, 2015, Clinical Cancer Research.

Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck

F. Khuri, D. Shin, T. Owonikoko, 2014, Cancer.